Literature DB >> 20553243

Sjögren's syndrome: a review of aetiology, pathogenesis, diagnosis and management.

K Bayetto1, R M Logan.   

Abstract

Sjögren's syndrome is a chronic autoimmune disease that affects many individuals within the community. Despite this, its exact aetiology and pathogenesis is still unclear. Sjögren's syndrome affects many organ systems in the body. However, for dental practitioners it is important to recognize the many oral and dental manifestations that are associated with the syndrome. In addition to these oral manifestations, this review will discuss the systemic manifestations of Sjögren's syndrome as well as the current understanding of factors that have a role in its aetiology and pathogenesis. Furthermore, this review will highlight the difficulties and complexities that are inherent in the diagnosis of Sjögren's syndrome and the important role that dental practitioners can play in the management of its oral manifestations. The effective management of oral manifestations and minimization of oral disease in patients with Sjögren's syndrome can result in improved quality of life for these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553243     DOI: 10.1111/j.1834-7819.2010.01197.x

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  29 in total

1.  Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation.

Authors:  Olutayo Odusanwo; Sreedevi Chinthamani; Andrew McCall; Michael E Duffey; Olga J Baker
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-11       Impact factor: 4.249

2.  Cerebellar degeneration in primary Sjӧgren syndrome.

Authors:  Mohammad Heidary; Samira Alesaeidi; Khashayar Afshari
Journal:  BMJ Case Rep       Date:  2018-06-06

Review 3.  Evaluation of different diagnostic criteria of diseases manifesting the oral cavity - A review. Part-1.

Authors:  Peeyush Shivhare; Ashish Gupta; Monu Yadav; Arvinda Konidena; Lata Shankarnarayan
Journal:  J Oral Biol Craniofac Res       Date:  2016-01-20

4.  Characterization of cognitive dysfunction in Sjögren's syndrome patients.

Authors:  Lynn C Epstein; Gina Masse; Jerold S Harmatz; Tammy M Scott; Athena S Papas; David J Greenblatt
Journal:  Clin Rheumatol       Date:  2013-12-15       Impact factor: 2.980

Review 5.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

6.  Remission of Sjogren's Syndrome after Roux-en-Y Gastric Bypass for Morbid Obesity.

Authors:  ShuYu Lim; WanXin Lim; Tikfu Gee
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

7.  The value of 68 Ga-PSMA-11 positron emission tomography/computerized tomography in evaluating the lacrimal and salivary glands function.

Authors:  Jian-Fang Li; Lu-Ping Qin; Qing-Yu Wu; Xing-Hua Guo; Jie-Zheng Yang; Qi-Chang Wan; Mu-Hua Cheng; Liang-Jun Xie
Journal:  Clin Rheumatol       Date:  2022-01-28       Impact factor: 2.980

8.  A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.

Authors:  Mihir Shah; Maria C Edman; Srikanth R Janga; Pu Shi; Jugal Dhandhukia; Siyu Liu; Stan G Louie; Kathleen Rodgers; J Andrew Mackay; Sarah F Hamm-Alvarez
Journal:  J Control Release       Date:  2013-07-25       Impact factor: 9.776

9.  A study of the effects of saliva stimulation by nizatidine on dry mouth symptoms of primary biliary cirrhosis.

Authors:  Tetsu Kikuchi; Katsuharu Hirano; Takuya Genda; Hironori Tsuzura; Shunsuke Sato; Yoshio Kanemitsu; Yutaka Narita; Katsuyori Iijima; Takafumi Ichida
Journal:  World J Hepatol       Date:  2013-03-27

10.  Subconjunctival dendrimer-drug therapy for the treatment of dry eye in a rabbit model of induced autoimmune dacryoadenitis.

Authors:  Hui Lin; Ying Liu; Siva P Kambhampati; Chih-Chien Hsu; Rangaramanujam M Kannan; Samuel C Yiu
Journal:  Ocul Surf       Date:  2018-05-16       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.